The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|June 29, 2015
Colorcon Adds Lab in Beijing
Author(s)Pharmaceutical Technology Editors
Colorcon expands its presence in China with a technical service center to serve the northern region.
Advertisement
Colorcon has announced that the company opened a new technical service laboratory in Beijing, China on June 25. Located in the Beijing YiZhuang Biomedical Park, the technical center is the company’s second facility in China and 19th worldwide.
Equipped for research-scale solid dose development, the laboratory support the development and commercialization pharmaceutical drug formulations from initial product concept, to pilot scale trials through to final production and registration.
The company established Shanghai Colorcon Coating Technology Limited in 1993 and made additional strategic investments in China in a supply chain and the local manufacture of Opadry film coatings.
Source:
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement